Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study
Publication
, Conference
Pollack, CV; Reilly, PA; van Ryn, J; Eikelboom, J; Glund, S; Bernstein, RA; Dubiel, R; Huisman, MV; Hylek, EM; Kamphuisen, PW; Kreuzer, J ...
Published in: CIRCULATION
December 20, 2016
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 20, 2016
Volume
134
Issue
25
Start / End Page
E714 / E715
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pollack, C. V., Reilly, P. A., van Ryn, J., Eikelboom, J., Glund, S., Bernstein, R. A., … Weitz, J. I. (2016). Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study. In CIRCULATION (Vol. 134, pp. E714–E715). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.
Pollack, Charles V., Paul A. Reilly, Joanne van Ryn, John Eikelboom, Stephan Glund, Richard A. Bernstein, Robert Dubiel, et al. “Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study.” In CIRCULATION, 134:E714–15. LIPPINCOTT WILLIAMS & WILKINS, 2016.
Pollack CV, Reilly PA, van Ryn J, Eikelboom J, Glund S, Bernstein RA, et al. Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2016. p. E714–5.
Pollack, Charles V., et al. “Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study.” CIRCULATION, vol. 134, no. 25, LIPPINCOTT WILLIAMS & WILKINS, 2016, pp. E714–15.
Pollack CV, Reilly PA, van Ryn J, Eikelboom J, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam C-W, Weitz JI. Idarucizumab For Dabigatran Reversal: Updated Results Of The Re-verse Ad Study. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2016. p. E714–E715.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 20, 2016
Volume
134
Issue
25
Start / End Page
E714 / E715
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology